Real-Fernandez et al. demonstrated that the synthetic glucosylated myelin oligodendrocyte glycoprotein fragment, (Asn31(Glc)hMOG(30–50)), was able to detect autoantibodies in MS patients. Here, MOG is linked to myeloid sarcoma.